Rhythm Pharmaceuticals (RYTM) had the highest return in July 2022 by a mid-cap US stock, returning 208.8%.

ASSET	MONTH	% RETURN
Rhythm Pharmaceuticals (RYTM)	July 2022	208.82%
Eos Energy Enterprises (EOSE)	July 2022	159.84%
Applied Digital (APLD)	July 2022	98.13%
Avadel Pharmaceuticals (AVDL)	July 2022	93.06%
Riot Blockchain (RIOT)	July 2022	72.64%
Calix (CALX)	July 2022	68.81%
Wingstop (WING)	July 2022	67.64%
Beam Therapeutics (BEAM)	July 2022	61.49%
Bel Fuse B (BELFB)	July 2022	58.66%
Cidara Therapeutics (CDTX)	July 2022	57%
Hut 8 Corp Common Stock (HUT)	July 2022	55.88%
Dyne Therapeutics (DYN)	July 2022	52.47%
Crocs (CROX)	July 2022	48.29%
Enphase Energy (ENPH)	July 2022	46.86%
Impinj (PI)	July 2022	46.84%
Catalyst Pharmaceuticals (CPRX)	July 2022	46.49%
Fluence Energy (FLNC)	July 2022	45.4%
Nuscale Power (SMR)	July 2022	44.12%
iRhythm Technologies (IRTC)	July 2022	43.39%
Praxis Precision Medicines (PRAX)	July 2022	42.91%
TG Therapeutics (TGTX)	July 2022	41.61%
Sunrun (RUN)	July 2022	39.53%
Uranium Energy (UEC)	July 2022	38.61%
Bel Fuse A (BELFA)	July 2022	38.31%
Herc (HRI)	July 2022	37.92%

Mid-cap stocks are treated as having a market cap between $2B and $10B.